Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ejphar.2021.173890 http://scihub22266oqcxt.onion/10.1016/j.ejphar.2021.173890 33482181!7816644!33482181     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Pharmacol 2021 ; 895 (ä): 173890 Nephropedia Template TP {{tp|p=33482181|t=2021. A review of potential suggested drugs for coronavirus disease (COVID-19) treatment |pdf=|usr=}}{{33482181}} gab.com Text A review of potential suggested drugs for coronavirus disease (COVID-19) treatment JO: Eur J Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33482181 #FOAvip The latest pandemic, coronavirus disease-2019 (COVID-19), is associated with high prevalence and easy transmission, which is expanding globally with no conventional treatment or vaccine. The new virus revealed 79% and 50% genomic similarities with severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), respectively. Accordingly, since the disease resists testing and adopting new therapeutics, repositioning pre-existing drugs may present a fast and attractive strategy with known safety, characteristics, and dosage used. However, they are not specific and targeted. Therefore, several drugs have been investigated for their efficacy and safety in the treatment of COVID-19; most of them are undergoing clinical trials. This article summarizes clinical investigations of potential therapeutic drugs used as COVID-19 therapy. Subsequently, it prepares a pattern of results and therapeutic targets to help further experiment designs. We have investigated drugs as classified in the following three groups; 1) The drugs which computationally showed effectiveness (in silico) but needed further lab confirmations; 2) Emetine, Teicoplanin, and Nelfinavir have shown effectiveness in vitro; 3) The drugs currently under clinical trial. Twit Text FOAVip A review of potential suggested drugs for coronavirus disease (COVID-19) treatment ????Eur J Pharmacol http://www.kidney.de/pget.php?&tw=1&pmid=33482181 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33482181 #FOAvip English Wikipedia <ref>{{Cite pmid|33482181}}</ref> A review of potential suggested drugs for coronavirus disease (COVID-19) treatment #MMPMID33482181 Tarighi P; Eftekhari S; Chizari M; Sabernavaei M; Jafari D; Mirzabeigi P Eur J Pharmacol 2021[Mar]; 895 (ä): 173890 PMID33482181show ga The latest pandemic, coronavirus disease-2019 (COVID-19), is associated with high prevalence and easy transmission, which is expanding globally with no conventional treatment or vaccine. The new virus revealed 79% and 50% genomic similarities with severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), respectively. Accordingly, since the disease resists testing and adopting new therapeutics, repositioning pre-existing drugs may present a fast and attractive strategy with known safety, characteristics, and dosage used. However, they are not specific and targeted. Therefore, several drugs have been investigated for their efficacy and safety in the treatment of COVID-19; most of them are undergoing clinical trials. This article summarizes clinical investigations of potential therapeutic drugs used as COVID-19 therapy. Subsequently, it prepares a pattern of results and therapeutic targets to help further experiment designs. We have investigated drugs as classified in the following three groups; 1) The drugs which computationally showed effectiveness (in silico) but needed further lab confirmations; 2) Emetine, Teicoplanin, and Nelfinavir have shown effectiveness in vitro; 3) The drugs currently under clinical trial. |*COVID-19 Drug Treatment[MESH] |Animals[MESH] |Antiviral Agents/*therapeutic use[MESH] |COVID-19/virology[MESH] |Humans[MESH] |Pandemics/prevention & control[MESH]A review of potential suggested drugs for coronavirus disease (COVID-1(epmc).pdf DeepDyve Pubget Overpricing